Stephen K. Wrigley

2.0k total citations
42 papers, 1.5k citations indexed

About

Stephen K. Wrigley is a scholar working on Pharmacology, Molecular Biology and Biotechnology. According to data from OpenAlex, Stephen K. Wrigley has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 17 papers in Molecular Biology and 9 papers in Biotechnology. Recurrent topics in Stephen K. Wrigley's work include Microbial Natural Products and Biosynthesis (22 papers), Fungal Biology and Applications (6 papers) and RNA and protein synthesis mechanisms (5 papers). Stephen K. Wrigley is often cited by papers focused on Microbial Natural Products and Biosynthesis (22 papers), Fungal Biology and Applications (6 papers) and RNA and protein synthesis mechanisms (5 papers). Stephen K. Wrigley collaborates with scholars based in United Kingdom, United States and Switzerland. Stephen K. Wrigley's co-authors include Vivian Miao, Richard H. Baltz, Paul Brian, Julia Penn, Steven Martin, Andrew Whiting, Robert C. Ford, Christopher J. Silva, Mario Bouchard and Ian B. Parr and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Communications and Scientific Reports.

In The Last Decade

Stephen K. Wrigley

42 papers receiving 1.4k citations

Peers

Stephen K. Wrigley

PHARM

BIOTE

ONCOL

Sonia I. Maffioli Italy

Sung Ryeol Park South Korea

Heather C. Losey United States

Brigitte Schlegel Germany

Muriel Gondry France

Ignacio Pérez‐Victoria Spain

Torsten Schwecke Germany

Takeo Miyaki Japan

Tin‐Wein Yu United States

John G. Ondeyka United States

Sonia I. Maffioli Italy

Stephen K. Wrigley

1.1k ×1.2

809 ×1.0

PHARM

253 ×0.8

BIOTE

361 ×1.3

62 ×0.5

ONCOL

Citations per year, relative to Stephen K. Wrigley Stephen K. Wrigley (= 1×) peers Sonia I. Maffioli

Countries citing papers authored by Stephen K. Wrigley

Since Specialization

Citations

This map shows the geographic impact of Stephen K. Wrigley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen K. Wrigley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen K. Wrigley more than expected).

Fields of papers citing papers by Stephen K. Wrigley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen K. Wrigley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen K. Wrigley. The network helps show where Stephen K. Wrigley may publish in the future.

Co-authorship network of co-authors of Stephen K. Wrigley

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen K. Wrigley. A scholar is included among the top collaborators of Stephen K. Wrigley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen K. Wrigley. Stephen K. Wrigley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steele, Jonathan, et al.. (2024). Small molecule drug metabolite synthesis and identification: why, when and how?. Drug Discovery Today. 29(5). 103943–103943. 1 indexed citations

Cho, Sungjoon, Lionel Cheruzel, Jingwei Cai, et al.. (2024). Discovery of Unprecedented Human Stercobilin Conjugates. Drug Metabolism and Disposition. 52(9). 981–987. 3 indexed citations

Kobylinski, Kevin C., Patchara Sriwichai, Siriporn Phasomkusolsil, et al.. (2023). Ivermectin metabolites reduce Anopheles survival. Scientific Reports. 13(1). 8131–8131. 9 indexed citations

Wrigley, Stephen K., et al.. (2020). Biotransformation: Impact and Application of Metabolism in Drug Discovery. ACS Medicinal Chemistry Letters. 11(11). 2087–2107. 70 indexed citations

Mbekeani, Alison, Rebecca Jones, Clément Regnault, et al.. (2019). Mining for natural product antileishmanials in a fungal extract library. International Journal for Parasitology Drugs and Drug Resistance. 11. 118–128. 9 indexed citations

Ellinger, Bernhard, Anjali Prashar, Johannes Landskron, et al.. (2014). A Phenotypic Screening Approach to Identify Anticancer Compounds Derived from Marine Fungi. Assay and Drug Development Technologies. 12(3). 162–175. 6 indexed citations

Nguyen, Kien T., et al.. (2006). A glutamic acid 3‐methyltransferase encoded by an accessory gene locus important for daptomycin biosynthesis in Streptomyces roseosporus. Molecular Microbiology. 61(5). 1294–1307. 56 indexed citations

Baltz, Richard H., Vivian Miao, & Stephen K. Wrigley. (2005). Natural products to drugs: daptomycin and related lipopeptide antibiotics. Natural Product Reports. 22(6). 717–717. 297 indexed citations

Baltz, Richard H., Paul Brian, Vivian Miao, & Stephen K. Wrigley. (2005). Combinatorial biosynthesis of lipopeptide antibiotics in Streptomyces roseosporus. Journal of Industrial Microbiology & Biotechnology. 33(2). 66–74. 47 indexed citations

10.

Penn, Julia, Xiang Li, Andrew Whiting, et al.. (2005). Heterologous production of daptomycin in Streptomyces lividans. Journal of Industrial Microbiology & Biotechnology. 33(2). 121–128. 62 indexed citations

11.

Waters, Barbara, et al.. (2002). Identifying Protein Kinase Inhibitors Using an Assay Based on Inhibition of Aerial Hyphae Formation in Streptomyces.. The Journal of Antibiotics. 55(4). 407–416. 55 indexed citations

12.

Wrigley, Stephen K., Martin A. Hayes, Steven M. Martin, et al.. (2000). Novel Streptopyrroles from Streptomyces rimosus with Bacterial Protein Histidine Kinase Inhibitory and Antimicrobial Activities.. The Journal of Antibiotics. 53(1). 1–11. 29 indexed citations

13.

Wrigley, Stephen K., Martin A. Hayes, Thomas Robert, Ewan J. T. Chrystal, & Neville Nicholson. (2000). New Leads for the Pharmaceutical and Agrochemical Industries.. 3 indexed citations

14.

Wrigley, Stephen K., Roya Sadeghi, Andrew Whiting, et al.. (1999). A Novel (6S)-4,6-Dimethyldodeca-2E,4E-dienoyl Ester of Phomalactone and Related .ALPHA.-Pyrone Esters from a Phomopsis sp. with Cytokine Production Inhibitory Activity.. The Journal of Antibiotics. 52(10). 862–872. 8 indexed citations

15.

Rawlins, Philip B., Roya Sadeghi, Guy Gammon, et al.. (1999). Inhibition of endotoxin-induced TNF-α production in macrophages by 5Z-7-oxo-zeaenol and other fungal resorcylic acid lactones. International Journal of Immunopharmacology. 21(12). 799–814. 22 indexed citations

16.

Wrigley, Stephen K.. (1997). Phytochemical diversity : a source of new industrial products. 14 indexed citations

17.

Rawlins, Philip B., et al.. (1997). XR651, A Novel Naphthacene-5,12-dione.. The Journal of Antibiotics. 50(2). 169–171. 2 indexed citations

18.

Hayes, Martin A., Stephen K. Wrigley, Elwood E. Reynolds, et al.. (1996). Novel Drimane Sesquiterpene Esters from Aspergillus ustus var. pseudodeflectus with Endothelin Receptor Binding Activity.. The Journal of Antibiotics. 49(6). 505–512. 37 indexed citations

19.

Wrigley, Stephen K., Elwood E. Reynolds, Martin A. Hayes, et al.. (1995). Azapbilones with Endothelin Receptor Binding Activity Produced by Penicillium sclerotiorum: Taxonomy, Fermentation, Isolation, Structure Elucidation and Biological Activity.. The Journal of Antibiotics. 48(9). 913–923. 59 indexed citations

20.

Depledge, Paul, Stephen K. Wrigley, Jan Mous, et al.. (1993). CD4-binding compounds: An assay to detect new classes of immunopharmacological agents. International Journal of Immunopharmacology. 15(3). 361–369. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact